As the year closes, one can’t help but reflect. So, we take a look back at our most popular blog posts from 2014. During the last 12 months, Chempetitive Group’s blog published articles on topics ranging from science marketing and biotech funding to the state of health care and trends in media. So, if you missed them the first time around, don’t worry. We’ve served them up here again for you. You’re welcome.
If you have ideas for articles you’d like to see here in the following year, reach out to us on Twitter (@chempetitive) or [send us a note](/contact.
We wish you a prosperous 2015!
- Top 10 Biotech IPOs of 2014 Take a look at the biotech IPOs that raised the most money in the last year, based on Fierce Biotech’s annual ranking. Ultragenyx tops the list.
- A Strategy and Tactic Walk Into a Bar Do you know the difference between strategies and tactics; between goals and objectives? These terms are often blurred into a not-so-tasty cocktail of marketing jargon, but we offer some clarity.
- Replacing Adderall: Medicines That Will Change the World Learn the story of a novel non-stimulant medication for attention deficit hyperactivity disorder, a condition that affects an estimated 5 percent of children.
- Why Your Brain Is Wired to Love Print Humans are wired to more effectively consume and retain information that’s printed out and in our hands. There’s plentiful scientific research to back this up — research that gives credence to the continued use of print media and also provides valuable insight into creating a more effective online experience for customers.
- Good Content Strategy Means Looking Within When it comes to content marketing, as the great philosopher David Lee Roth once said, “Everybody wants some!” But too often, organizations skip directly to the fun part: the tactics.
- Future of MedTech: Who’s In, Who’s Out, Who’s Taking Over A wave of megamergers (think Covidien + Medtronic) and impressive IPO performances in 2014 are signs that the tide is turning.
- Fecal Transplants: Sounds Gross, Saves Lives Fecal transplants, also known as fecal microbiota transplantations, involve placing gut microorganisms from the stool of a healthy donor into an infected individual, essentially restocking the healthy bacteria that antibiotics and infections have destroyed.
- Science Goes Indie: Can the ‘Crowd’ Fill the Funding Gap? Grant money is hard to get. Investors are more skittish than we’d like. Yet independent researchers all over the world are on the verge of a breakthrough, just needing the cash to make it happen.
- Life Science Content Marketing: 8 Ways to Discreetly Build Your Brand From white papers to infographics, find specific examples of content that could help win credibility points with your audience.
- Marketing With a Magnet, Not a Hammer: Why Biotech Brands Need a Good Digital Strategy Inbound marketing will help you cut through the marketing static that target audiences have learned to ignore.